md phd washu

Let your curiosity lead the way:

Apply Today

• Arts & Sciences
• Graduate Studies in A&S

M.D./Ph.D. Programs or Medical Scientist Training Programs (MSTP) train physician-scientists to become leaders in biomedical research. Students who pursue this option obtain both an M.D. and a Ph.D. degree with in-depth training in modern biomedical research and clinical medicine. The typical M.D./Ph.D. career combines patient care and biomedical research but leans toward research. It is an excellent choice for students who are passionate about research and are certain that research will be an important dimension of their careers.

Since they are completing two graduate degrees, M.D./Ph.D. students spend a longer period of time in graduate training. Generally, however, your tuition is paid by federal or institutional grants, and you receive a stipend. So, even though the time to degree (and practice) is longer, you may graduate debt-free. Average program length is 7 - 8 years; however, M.D./Ph.D. graduates, on average, are in a position to secure funding to direct a research lab in fewer years than M.D. graduates who pursue research fellowships after residency.

The types of Ph.D.s that can be combined vary considerably from institution to institution. Some institutions only offer Ph.D.s in scientific fields while others are more flexible. You should research each program individually to evaluate its offerings.

Most M.D./Ph.D. programs arrange for a student to take off from medical school between the second and third years (after the preclinical portion of medical school) to complete his or her PhD. The student then returns after three to seven (typically four) years to resume medical school by beginning the clinical portion. The student is normally awarded both degrees together upon graduating from medical school after a total of seven to ten years.

Exposure to the Field

Shadowing & volunteering.

Some shadowing and experience in a hospital setting is important, but since physician-scientists will spend most of their careers in a laboratory, a student’s research experience is the most important experiential dimension of the application.

The Application Process

Of the 71 MD-PhD programs, 36 do not accept non-U.S. citizens, but many top-tier research institutions (including Washington University School of Medicine) fund some MD/PhD positions through private sources and welcome international students to apply for those seats. For undergraduate students interested in biomedical research, the MD/PhD programs offer an excellent opportunity. Undergraduates interested in an MD/PhD program will need to establish an outstanding academic record and a genuine commitment to doing research. Most successful applicants are science majors and have been in the laboratory since their sophomore summer in college and have completed a thesis. Students who are interested in this program and wish to major in the humanities or the social sciences should also plan to pursue a second major in one of the sciences.

Timeline Some schools require a formal PhD application to be submitted simultaneously with your application to the medical school. In this case, your application is first processed by the medical school admissions committee. If you are accepted to the medical school, the application is then forwarded to the graduate school admissions committee, which evaluates on separate grounds to determine your admission. Some programs allow application to the PhD portion of an MD/PhD program after entering medical school. Undergraduate Experience MD/PhD applicants should have significant research experience, and a science major. Grades and MCAT are important, but one’s potential as a future scientist is the most important consideration in the selection process. At Washington University, while most of our students who apply to MD/PhD programs happen to have astonishingly good credentials, students who are passionate about their research can absolutely enter an MD/PhD program with more modest science grades and MCAT scores. 30% of the successful MD-PhD applicants from WU in 2004 - 2008 had a science GPA below 3.5, or an MCAT below 33, or both. Of all our applicants from the College of Arts & Sciences to MD/PhD programs in the last five years, 85% were admitted, a very high rate of success. Research Prospective MD/PhD candidates should be especially intent on getting as much undergraduate research experience as possible prior to applying. The depth and quality of the research experience is of greater importance than the particular area of investigation. Many candidates will have already authored or co-authored research publications before their graduation. Standardized Tests Many MD/PhD programs require GRE exams in your PhD area. If you don’t know explicitly that the schools to which you are applying do not require them, then you should expect to take them. Letters of Reference Compelling letters of recommendation from research mentors are crucial. You must obtain reference letters from all of your undergraduate research supervisors.

Professional Opportunities

An MD/PhD often leads to becoming a faculty member at a medical school, university or research institute such as the National Institutes of Health (NIH).  A few MD/PhD graduates opt for research careers in the private sector.

The MD/PhD Programs The types of PhDs that can be combined vary considerably from institution to institution. Some institutions only offer PhDs in scientific fields while others are more flexible. You should research each program individually to evaluate its offerings. General Structure Most MD/PhD programs arrange for a student to take off from medical school between the second and third years (after the preclinical portion of medical school) to complete his or her PhD. The student then returns after three to seven (typically four) years to resume medical school by beginning the clinical portion. The student is normally awarded both degrees together upon graduating from medical school after a total of seven to ten years.

MD-PhD Training and Careers

A guide for potential applicants, current trainees, and advisors, the american association of medical colleges website has extensive md/phd information, premd/phd advisor:.

Kristin Sobotka [email protected] Office: Cupples II, Suite 104 Online Appointment Password: research

Division of Biology & Biomedical Sciences

• WUSTL Medical Scientist Training Program (MSTP) – Dual MD/PhD

Washington University in St. Louis’s Medical Scientist Training Program (MSTP) is designed to prepare students for careers as physician-scientists who are engaged in biomedical research that creates new knowledge for the betterment of society. Established in 1969, MSTP has successfully trained and graduated over 700 physician-scientists, with more than 80% of graduates engaged in academic medicine, employed with the National Institute of Health (NIH), or employed in the pharmaceutical/biotechnology industry.

Drawing on the combined resources of Washington University, Barnes-Jewish Hospital and St. Louis Children’s Hospital, the MSTP is a well-integrated program that combines outstanding medical training with rigorous PhD studies in biomedical research. Graduates of the program are not physicians and scientists, but physician-scientists who think about clinical and research problems in unique and innovative ways.

Learn more »

• Letter from the Dean
• Graduate Course of Study
• Stipends, Benefits & Grants
• DBBS Hooding & Recognition Ceremony
• DBBS 50th Anniversary Celebration April 28-29, 2023
• Video Gallery
• Living in St. Louis

JOHN T. MILLIKEN DEPARTMENT OF MEDICINE

Cardiovascular Division

• Our Fellows

Current Trainees

Daniel K. Fox, MD, PhD

Cardiology Fellow, Washington University School of Medicine

Our primary area of study is focused on studying the spillover effects of the COVID-19 pandemic on cardiovascular care. We have focused our efforts on ascertaining how this viral pandemic affects utilization and outcomes for cardiovascular conditions (HF, AMI, stroke, arrhythmia), with the hypothesis that deferred care during COVID is associated with worsening clinical outcomes.

A second area of study is focused on understanding how value-based and alternative payment models impact utilization and outcomes. Specifically, we are examining the impact of the Bundled Payments for Care Improvement-Advanced initiative on cardiovascular outcomes. We are also focused on determining which hospitals succeed (teaching, non-teaching), which patients succeed (young, old), whether there are differences in inpatient vs. outpatient Percutaneous Coronary Intervention (PCI), and whether there are unintended consequences for patient populations (poor, frail).

Arik Park, MD, PhD

Medical School:  University of Wisconsin School of Medicine and Public Health

Residency:  Barnes-Jewish Hospital at Washington University School of Medicine

Past Trainees

Ankit Garg, MD, PhD

Medical School:  University of Texas Southwestern Medical Center at Dallas Southwestern Medical School

Residency:  Hospital of the University of Pennsylvania

David Rawnsley, MD PhD

Instructor in Medicine Washington University School of Medicine

My research focuses on the role of lysosomes and autophagy in immune cells and cardiomyocytes in the setting of myocardial injury and repair.

Recent Publications:

Rawnsley DR., et al. Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat. EBioMedicine. 2020 Jun;56:102824.

Lin Chien-Jung, MD, PhD

Interventional Cardiologist St. Louis University Physicians

Lin CJ, et al., Cardiomyopathy in patients after posttransplant cyclophosphamide–based hematopoietic cell transplantation.  Cancer . 2017 Mar 15;123(10):1800-9.

Reinhardt S, et al., Non-invasive cardiac testing versus clinical evaluation alone in acute chest pain.  JAMA Int Med . 2018 Feb 1;178(2):212-9.

Lin CJ, et al., Insurance access in adults with congenital heart disease in the Affordable Care Act era.  Congenit Heart Dis . 2018 May;13(3):384-91.

Lin CJ, et al., Genetics of the extracellular matrix in aortic aneurysmal diseases.  Matrix Biol . 2018 Oct;71-72:128-43.

Lin CJ, et al., Heterogeneous cellular contributions to elastic laminae formation in arterial wall development.  Circ Res . 2019 Nov 8;125(11):1006-18.

Lin CJ, et al., RNA vaccines for COVID-19: five things every cardiologist should know.  JACC Basic Transl Sci.  2020 Dec;5(12):1240-1243.

Lin CJ, Mecham RP. Tissue-specific smooth muscle cell subtypes identified by transcriptional profiling.  Int J Biochem Cell Biol . 2021 Oct;139:106055.

Lin CJ, et al., Vascular smooth muscle cell subpopulation and neointimal formation in mouse models of elastin insufficiency.  Arterioscler Thromb Vasc Biol . 2021 Sep 30:ATVBAHA120315681.

Luigi Adamo, MD, PhD

Assistant Professor of Medicine Johns Hopkins University

“B lymphocytes are the second most prevalent leukocyte population in the heart and they have been shown to play a key role in the myocardial response to injury. Surprisingly very little is known about them. I am working to broaden our understanding of the biology of myocardial B lymphocytes with the goal of the developing innovative B cell focused therapies for the treatment of heart failure.”

Adamo L, et al. The Emerging Role of B Lymphocytes in Cardiovascular Disease. Annu Rev Immunol. 2020 Apr 26;38:99-121.

Adamo L, et al. Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. JCI Insight. 2020 Feb 13;5(3):e134700

Joshua Brettmann, PhD

Senior scientist at Millipore Sigma

Kir2.1 is crucial for setting the resting membrane potential and misregulation of this channel have significant impact on the timing of cardiac action potentials, with mutations leading to both long and short QT syndromes. My project looks to understand the molecular mechanism of this crucial channel by using single molecule FRET to determine the structural and dynamic consequences of lipid binding.

Wang S, et al. Studying Structural Dynamics of Potassium Channels by Single-Molecule FRET. Methods Mol Biol. 2018;1684:163-180.

Brettmann JB, et al. Role of protein dynamics in ion selectivity and allosteric coupling in the NaK channel. Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15366-71.

Peter Crawford, MD, PhD

Professor, Departments of Medicine, and Biochemistry, Molecular Biology, and Biophysics Vice Chair for Research, Department of Medicine Director, Division of Molecular Medicine University of Minnesota

Our group performs studies in animal models and humans to learn how alterations of ketone metabolism and related pathways may serve as diagnostic biomarkers and therapeutic targets for obesity, diabetes, nonalcoholic fatty liver disease (NAFLD/NASH), and heart failure. We leverage recent advances in stable isotope tracer based NMR and mass spectrometry-based untargeted metabolomics technologies to study metabolism on a systems level, and we also employ established techniques in molecular cell biology and biochemistry to reveal phenotypic shifts at the cellular level.

Recent Publication:

d’Avignon DA, et al. Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome. JCI Insight. 2018 Jun 21;3(12).

Sharon Cresci, MD

Associate Professor of Medicine (Tenured) and Associate Professor of Genetics Washington University School of Medicine

The focus of my research is the association of genetic variation with clinical outcomes in patients with cardiovascular disease and in the variable response to pharmacologic treatment. I have specific interest in (1) the contribution of genetic variation to racial disparities in response to medical treatments used to treat coronary syndromes and in outcomes in patients with coronary artery disease and (2) defining the functional mechanism of these genetic associations; the ultimate goal of my research is to promote and advance precision medicine approaches.

Cresci S, et al. Cytochrome p450 gene variants, race, and mortality amongclopidogrel-treated patients after acute myocardial infarction. Circ CardiovascGenet. 2014 Jun;7(3):277-86.

Slava Epelman, MD, PhD

Assistant Professor of Medicine, University of Toronto Loretta Rogers Chair in Immunobioengineering Toronto General Hospital Research Institute Peter Munk Cardiac Centre

We study cardiac immune cell heterogeneity and the role of individual immune cell subsets in cardiac tissue injury, repair and regeneration.

Clemente-Casares X, et al. A CD103(+) Conventional Dendritic Cell Surveillance System PreventsDevelopment of Overt Heart Failure during Subclinical Viral Myocarditis.Immunity. 2017 Nov 21;47(5):974-989.

Brian Finck, PhD

Associate Professor in Medicine Washington University School of Medicine

The Finck lab studies basic aspects of intermediary metabolism in heart, skeletal muscle, and liver. We have ongoing projects to study the role of key proteins that control lipid synthesis and mitochondrial metabolism of fatty acids and pyruvate.

McCommis KS, et al. Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling. Cell Metab. 2015 Oct 6;22(4):682-94.

Gmerice Hammond, MD, PhD

The goal of my research is to understand the impact of health care policy on vulnerable populations challenged by social determinants of health. I seek to understand how health care policies, particularly value based payment models positively or negatively influence health care systems to address the needs of socially high risk populations. My work also examines ways to bring social determinants of health into clinical risk prediction models in order to reduce inequities in cardiovascular risk prediction and the resultant inequitable distribution of preventive services and treatments.

Hammond G, Joynt Maddox KE. A Theoretical Framework for Clinical Implementation of Social Determinants of Health.  JAMA Cardiol . 2019;4(12):1189-1190. doi:10.1001/jamacardio.2019.3805

Hammond G, Luke AA, Elson L, Towfighi A, Joynt Maddox KE. Urban-Rural Inequities in Acute Stroke Care and In-Hospital Mortality.  Stroke . 2020;51(7):2131-2138. doi:10.1161/STROKEAHA.120.029318

Hammond G, Johnston K, Huang K, Joynt Maddox KE. Social Determinants of Health Improve Predictive Accuracy of Clinical Risk Models for Cardiovascular Hospitalization, Annual Cost, and Death.  Circ Cardiovasc Qual Outcomes . 2020;13(6):e006752. doi:10.1161/CIRCOUTCOMES.120.006752

Christopher Holley, MD, PhD

Assistant Professor of Medicine Duke University

The goal of my laboratory at Duke University is to understand how emerging aspects of RNA biology contribute to cardiovascular health and disease, then translate those findings into novel therapeutic approaches for patients. Right now, I am particularly interested in studying how non-coding RNAs and RNA modifications play a role in heart failure.

Fry NJ, et al. N(6)-methyladenosine is required for the hypoxic stabilization of specific mRNAs. RNA. 2017Sep;23(9):1444-1455.

Ali Javaheri, MD, PhD

Assistant Professor of Medicine Washington University School of Medicine

Ali Javaheri’s research broadly focuses on the role of lipoproteins in inter-organ cross talk and organ injury. The laboratory is presently focused on the role of apolipoprotein M, a lipoprotein that binds the bioactive lipid sphingosine-1-phosphate. The Javaheri laboratory utilized human, murine, and in vitro models to better understand the role of lipoproteins in disease relevant models ranging from heart failure, chemotherapy-induced cardiotoxicity to sepsis.

Javaheri A, et al. Circulating Ceramide 16:0 in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2020 May 5;75(17):2273-2275.

Javaheri A, et al. TFEB activation in macrophages attenuates postmyocardial infarction ventricular dysfunction independently of ATG5-mediated autophagy. JCI Insight. 2019 Nov 1;4(21):e127312.

Jesus Jimenez, MD, PhD

Overarching goal is to understand how CD40 signaling, an emerging immune checkpoint target, reshapes cardiac macrophage composition and behavior in the context of two common cardiac comorbidities, hypertensive heart disease and myocardial infarction.

Lipovsky CE*, Jimenez J* et al. Chamber-specific transcriptional responses in atrial fibrillation. JCI Insight. 2020;135319.

Jimenez J, Rentschler SL. DNA damage prediction tool: Don’t go breaking my heart. JACC Basic Transl Sci. 2019 Oct 28;4(6):681-683.

Jimenez J, Rentschler SL. Transcriptional and Epigenetic Regulation of Cardiac Electrophysiology. Pediatr Cardiol. 2019 Oct;40(7):1325-1330.

Benjamin Kopecky, MD, PhD

Assistant Professor of Medicine University of Colorado

Macrophages are the most abundant donor immune cell at the time of transplant.  Recent paradigm shifting studies have shown remarkable heterogeneity among tissue resident macrophages.  I am working toward broadening our understanding of donor macrophage activation and interaction with the recipient immune populations at the time of heart transplantation.  Insights gained can be translated towards prevention or earlier intervention of primary graft dysfunction and acute cellular rejection.

Kopecky BJ, et al. Role of donor macrophages after heart and lung transplantation. Am J Transplant. 2020 May;20(5):1225-1235.

David Lanfear, MD

Head, Advanced Heart Failure and Transplant Cardiology, Professor of Medicine, Henry Ford Hospital

Research focus is genomics and precision medicine for heart failure, HF clinical trials, and the care of the adv. Hf patients (LVAD outcomes, pt selection, etc.).

Lanfear DE,et al.Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients. JACC Heart Fail. 2017 Nov;5(11):823-832.

Kory Lavine, MD, PhD

Assistant Professor Washington University School of Medicine

The primary goal of our laboratory is to identify new approaches to treat patients with heart failure. Specific projects in the laboratory are focused on unraveling the mechanisms that initiate disease pathogenesis using a precision medicine approach and defining the role of the immune system in cardiac tissue homeostasis, heart failure progression, and myocardial tissue repair.

Bajpai G, et al.Thehuman heart contains distinct macrophage subsets with divergent origins andfunctions. Nat Med. 2018 Jun 11. doi: 10.1038/s41591-018-0059-x. [Epub ahead ofprint].

Jonathan Moreno, MD, PhD

My research focus is on utilizing computational approaches to mathematically describe the biology of ion channels, which are critically important for cellular excitability. These models allow us to design better treatment strategies for the pharmacological management of heart failure and arrhythmia. Using computational tools and clinical datasets, I also am interested in drug-repositioning – using old drugs for new targets in novel ways. My current project is focused on building a computational model of the cardiac Na+ channel that incorporates voltage clamp fluorometry data (VCF) to track voltage-sensing domain (VSD) movement of the Na+ channel during an action potential. By incorporating VSD kinetics into a multi-scale model of the heartbeat, we can better understand the molecular movements that drive antiarrhythmic efficacy (or failure) of certain long-QT mutation carriers in response to commonly prescribed anti arrhythmic drugs.

Moreno JD, et al. A Molecularly Detailed Na V 1.5 Model Reveals a New Class I Antiarrhythmic Target. JACC Basic Transl Sci. 2019 Oct 28;4(6):736-751. 

Moreno JD, et al. Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation. Circ Res. 2019 Feb 15;124(4):539-552.

Babak Razani, MD, PhD

Professor of Medicine University of Pittsburgh

Babak Razani’s research broadly focuses on the mechanisms of atherosclerosis and related metabolic conditions. We have taken a particular interest in the autophagy-lysosome system as it is a cellular process that appears to be affected in a variety of these diseases.

Sergin I, et al. Exploitingmacrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis. NatCommun. 2017 Jun 7;8:15750.

Michael Sack, MD, PhD

Chief, Cardiovascular Branch, Division of Intramural Research NHLBI and Director of Laboratory of Mitochondrial Biology and Metabolism

Studying the role of nutrient sensing and acetylation in the control of mitochondrial biology and metabolism. My laboratory has extended this work into the translational space exploring these concepts in the control of immune function and inflammation.

Wang L, et al. GCN5L1modulates cross-talk between mitochondria and cell signaling to regulate FoxO1stability and gluconeogenesis. Nat Commun. 2017 Sep 12;8(1):523.

Joel Schilling, MD, PhD

Assistant Professor of Medicine Pathology & Immunology

My lab is focused on understanding the effects of obesity and diabetes on macrophage function. Our goal is to dissect the biology of distinct macrophage populations in vivo to design novel approaches to treat complications of metabolic disease.

He L, et al. Inhibition of mTOR reduces lipotoxiccell death in primary macrophages through an autophagy-independent mechanism. JLeukoc Biol. 2016 Nov;100(5):1113-1124.

• Cardiology Fellowship Training
• Research Faculty
• Facilities & Resources
• Seminars and Events
• How to Apply
• Hear From Our Fellows
• Wellness Committee
• Cardiolovascular Grand Rounds
• Diversity, Equity, and Inclusion in Cardiovascular Training

Medical Scientist Training Program

Find current students by entering a name, PhD program, advisor name, undergraduate university or research keyword in the search bar; selecting a PhD program from the drop-down menu; or selecting the last name initial from the A-Z filter.

Click on an individual’s name to see their research summary and graduate publications.

• All PhD Program
• Biochemistry Biophysics and Structural Biology
• Biomedical Engineering
• Biomedical Informatics and Data Science
• Cancer Biology
• Computational and Systems Biology
• Developmental Regenerative and Stem Cell Biology
• Human and Statistical Genetics
• Molecular Cell Biology
• Molecular Genetics and Genomics
• Molecular Microbiology and Microbial Pathogenesis
• Neurosciences
• Philosophy Neuroscience and Psychology
• Philosophy Neuroscience Psychology
• Systems Science & Mathematics
• Systems Science and Mathematics
• Unspecified

Jesus Acevedo Cintron

Program: Developmental Regenerative and Stem Cell Biology

Current advisor: Susan Mackinnon, MD

Undergraduate university: University of Puerto Rico-Rio Piedras

Lucas Adams

Program: Immunology

Current advisor: Daved H. Fremont, PhD

Undergraduate university: Oklahoma Baptist University

Favour Akinjiyan

Program: Molecular Genetics and Genomics

Current advisor: Gregory D. Longmore, MD

Undergraduate university: New York Institute of Technology

Junedh Amrute

Program: Computational and Systems Biology

Current advisor: Kory J. Lavine, MD, PhD

Undergraduate university: California Institute of Technology

Shashank Anand

Program: Biomedical Engineering

Current advisor: Daniel W. Moran, PhD

Undergraduate university: University of California-San Diego

Program: Molecular Microbiology and Microbial Pathogenesis

Current advisor: Siyuan Ding, PhD

Undergraduate university: University of Maryland-College Park

Artem Arutyunov

Program: Neurosciences

Current advisor: Robyn S. Klein, MD, PhD

Undergraduate university: Moscow State University

Corvin Arveseth

Current advisor:

Undergraduate university: University of Utah

Josselyn Barahona

Current advisor: Wayne M. Yokoyama, MD

Undergraduate university: Williams College

Laura Baratta

Program: Biomedical Informatics and Data Science

Current advisor: Thomas G. Kannampallil, PhD

Undergraduate university: Temple University

Lili Barbar

Current advisor: Aaron DiAntonio, MD, PhD

Undergraduate university: Case Western Reserve University

Derek Barisas

Current advisor: Kyunghee Choi, PhD

Undergraduate university: Washington & Lee University

Current advisor: Ting Wang, PhD

Undergraduate university: Columbia University

Jesus Bazan Villicana

Current advisor: Scott J. Hultgren, PhD

Undergraduate university: Indiana University-Bloomington

Jacob Bedia

Undergraduate university: Stanford University

Current advisor: David G. DeNardo, PhD

Undergraduate university: McGill University

Zachary Beller

Current advisor: Jeffrey I. Gordon, MD

Undergraduate university: Washington University

Druv Bhagavan

Current advisor: Jonathan R. Silva, PhD

Undergraduate university: Yale University

Current advisor: Timothy M. Miller, MD, PhD

Undergraduate university: University of Alabama-Birmingham

Current advisor: Harrison W. Gabel, PhD

Undergraduate university: Duke University

• Administration and Staff

The central resource for MD students

Find the information, support and services you need to thrive as a WashU medical student — academically and beyond.

Gateway Curriculum

The Washington University School of Medicine’s Gateway Curriculum empowers future academic physicians to lead the advancement of human health.

Read more about our curriculum »

Find your perfect residency match!

Match Day will be here before you know it, and we want you to get the residency of your dreams. The Residency Roadmap website will help you successfully prepare and find your perfect match.

Visit the Residency Roadmap »

Interested in research?

No matter your career goal, research can be an important part of medical training. Opportunities abound in basic, translational or clinical research. We’re here to help you find the best fit.

Learn more about research »

Wellness resources support all areas of life

Everyone needs a little help from time to time. WashU’s wellness resources are here to support you in all areas of MD student life — academic, financial, mental, physical, social and spiritual.

Explore wellness resources »

Announcements

Updates on campus events, policies, construction and more.

• I2DB Symposium April 12: The Power of AI in Medicine
• Notice of data security incident
• COVID-19: Medical Campus updates
• Affordable mental health care for employees and their children

close  

Information for Our Community

Whether you are part of our community or are interested in joining us, we welcome you to Washington University School of Medicine.

• Prospective Students
• Current Students
• Alumni & Friends
• Administrators
• Researchers
• Job Seekers

WashU Medicine reaches new heights as it climbs to No. 3 in NIH research funding

Research flourishes despite the immense challenges of the pandemic

February 7, 2023

Guoyan Zhao, PhD, discusses research projects with (from left) research analyst Kevin Boyer and postdoctoral research associate Wei Feng, PhD, at Washington University School of Medicine in St. Louis. Zhao recently received her first R01 grant from the National Institutes of Health (NIH), a milestone achievement. WashU Medicine has risen to No. 3 among U.S. medical schools in total NIH research funding support.

Scientists at Washington University School of Medicine in St. Louis were awarded $569 million in research grants from the National Institutes of Health (NIH) in federal fiscal year 2022, elevating WashU to No. 3 among U.S. medical schools in total NIH research funding support. The new ranking surpasses last year’s impressive research successes, when WashU Medicine rose to No. 4.

Remarkably, WashU Medicine capped its momentous year in biomedical research despite the ongoing challenges of the COVID-19 pandemic. Since 2016, when NIH research funding to WashU Medicine totaled $374 million, support has grown by 52% with more than 120 new NIH-funded investigators.

“No. 3 is an incredible achievement,” said Chancellor Andrew D. Martin. “WashU Medicine is known worldwide for the caliber of its biomedical research. Many of our researchers are leaders in their fields, and their programs provide an incredible training ground for students and trainees who are just starting careers of their own.”

NIH support makes up the majority of extramural grants for research at WashU Medicine. With grants from other sources — including foundations, donors and government agencies such as the Centers for Disease Control and Prevention — as well as institutional support and collaborations with industry, research investments at WashU Medicine in 2022 totaled almost $1.2 billion.

In the 2022 federal fiscal year rankings of NIH funding, the medical schools at the University of California, San Francisco, and Stanford were No. 1 and No. 2, respectively, with the medical schools at Johns Hopkins University and the University of Pennsylvania rounding out the top five.

WashU Medicine’s No. 3 ranking in NIH research funding reflects the quality and rigor as well as the breadth and depth of the school’s research efforts. The bulk of NIH dollars to WashU Medicine funds innovative, investigator-initiated research projects aimed at answering pressing questions in science and medicine. NIH grant applications go through an intensive peer-review process, and only about 30% of projects are selected for funding. NIH grants are particularly sought after because they also include the most significant level of funding for the facilities and infrastructure that makes research possible, unlike grants from many other organizations.

An important part of WashU’s mission is elevating and nurturing the careers of the next generation of outstanding research faculty, particularly women and those underrepresented in medicine and biomedical sciences, who will carry on the tradition of research excellence. Each year, an estimated three dozen or more early-career scientists at WashU Medicine receive their first R01 grants. These grants provide up to five years of support and are a milestone achievement. Among the faculty who recently received a first R01 grant is Guoyan Zhao, PhD, an assistant professor of neuroscience. The grant supports Zhao’s research into neurodegenerative conditions such as Parkinson’s disease and Lewy body dementia.

“I was so thrilled that my grant was funded after the first submission,” she said. “There is so much to learn about how neurodegenerative conditions develop, such as why degeneration occurs in certain parts of the brain and not others, and why certain types of neurons are more vulnerable to damage than others. This kind of information is crucial for learning how to prevent and treat neurodegenerative diseases.”

NIH grants support research in many different areas, and the breadth is exemplified by prominent studies such as the Adolescent Brain Cognitive Development Study , which investigates how life experiences, along with a child’s changing biology, affect brain development; a major project to develop and evaluate a broadly protective vaccine against coronaviruses , including all variants of the virus that causes COVID-19; and long-running international clinical trials evaluating therapies for inherited Alzheimer’s disease . NIH support also enabled WashU Medicine physician-scientists to establish a Pediatric Center of Excellence in Nephrology to study the genetic and molecular underpinnings of childhood kidney disease and improve care for children with such diseases; a Center for Perioperative Mental Health to study ways to identify and treat depression and anxiety in surgical patients; and a Silvio O. Conte Center for Basic Neuroscience Research , one of 15 awarded by the National Institute of Mental Health, to advance research into neurosteroids as treatments for depression and other psychiatric disorders.

In just the past two years, research led by NIH-supported WashU Medicine scientists has been translated into a nasal vaccine for COVID-19 , now authorized for use in India and under development in the U.S.; a blood test for Alzheimer’s disease that can be used as a low-cost, easily accessible alternative to expensive brain scans and invasive spinal taps; and a brain-computer interface device designed to help chronic stroke patients retrain their brains to gain more use of their hands and arms.

Success in NIH funding is an objective measure of scientific competitiveness, because grant applications undergo extensive peer review. It also is used by many medical schools as a metric for benchmarking research capabilities, because the data is available through the public NIH website and therefore entirely verifiable. Other rankings, such as those developed by U.S. News & World Report, use research metrics that cannot be verified by databases available to the public. This is one reason, among other very important ones about medical education, why WashU Medicine and other leading medical schools have withdrawn from participating in U.S. News & World Report’s annual “Best Medical Schools” survey and ranking. The medical schools at Harvard University, Stanford University, Columbia University and the University of Pennsylvania among others also have challenged the U.S. News rankings’ validity and have decided to no longer submit data to U.S. News & World Report.

“We believe in the value of research for advancing knowledge and improving health,” Perlmutter said. “Grants are not the object of our research mission, but they provide the bulk of the funding, and NIH funding, in particular, reflects the competitiveness and quality of our science. This isn’t about bragging rights, although I’m never shy about bragging about the amazing people we have at the med school.

“Holding a spot in the top tier of NIH funding means we have the resources and the talent to do the most innovative, potentially transformative research,” he said. “It means we can recruit the best scientists to join and enhance our community. It creates increased opportunities for collaboration with biotech and pharma companies. It is all part of the virtuous cycle of academic medicine: Great research leads to improvements in human health and patient care, and brings in funding for more research.”

Having such a flourishing research community at WashU Medicine has wide-ranging benefits. Clinicians have access to the most up-to-date medical knowledge and cutting-edge technologies, so they can provide the best possible care. Patients benefit from advances in preventing, diagnosing and treating disease. Students and trainees have access to world-class research opportunities and educators who are leaders in their fields. Federal and other outside funding for research injects dollars into the local and regional economies, helping to grow our city and our region. Some NIH-funded discoveries can be licensed by the university and commercialized, transforming research dollars into concrete improvements in preventing, diagnosing and treating disease. In this way, NIH funding benefits patients at our hospitals and clinics and around the world.

“We measure the success of the medical school on multiple metrics, and research funding is just one,” Perlmutter said. “Clinical care outcomes, quality of medical education, ability to provide care to the local community and contributions to the local economy are also key indicators. Despite metrics that illustrate our strong performance in these areas, our culture at WashU Medicine means that we’re always learning, growing and finding ways to improve what we do.

“Three years into the pandemic, our researchers continue to produce outstanding science, publishing many papers in top-tier journals every week, and our clinicians continue to provide exceptional care,” he added. “The dedication, perseverance and innovation of our faculty and staff during such a challenging time say a lot about what makes the School of Medicine such a special place and a leader among medical schools.”

• Click to share on Facebook (Opens in new window)
• Click to share on Twitter (Opens in new window)
• Click to share on Pinterest (Opens in new window)
• Click to share on LinkedIn (Opens in new window)

Editors' Picks

April 2, 2024

NIH-funded study seeks to fill gap in knowledge of exercise’s effects in people who use wheelchairs.

Medical Campus & Community, News Release

March 19, 2024

This year’s graduating class first to go completely through Gateway Curriculum.

Medical Campus & Community, Video

March 7, 2024

Ranking reflects success as thriving hub of scientific excellence, medical innovation.

Medical Campus & Community

Physician-Scientist Training Program (PePSTP)

Oliver langenberg physician-scientist training program.

Washington University and its Department of Pediatrics have a long and successful history of training pediatric physician-scientists.  Our Pediatric Physician-Scientist Training Program (PePSTP) was formalized in 2011, and the program has received substantial external support since 2013 from the Edward Mallinckrodt, Jr. Foundation. The foundation has provided a grant in memory of Oliver Langenberg, a St. Louis businessman and philanthropist who led the foundation for 50 years and died in 2012 at the age of 99.

Quick facts

• Our Pediatric Residency Program averages  5.5 MD/PhD interns  per entering class
• The PePSTP has inducted 33 trainees since 2012, has  graduated 15 trainees  and has  13 trainees currently  in the program
• Among PePSTP graduates who have applied for K awards, success rate is 100%; additional graduates have received subspecialty-specific career awards
• Overall, the Department of Pediatrics has a  K08 success rate of 95%  and  K-to-R success rate of 61% , both far above national averages

Key features

• A flexible, individualized training experience combining both clinical and research training.
• Enhanced mentoring to optimize transitions from clinical to scientific training and into the first academic faculty position.
• Preferential access into any of the subspecialty fellowships at Wash U and SLCH. 
• Discretionary educational funds and salary enhancement (see below).

The ultimate goal of the program is to ensure the successful launch of pediatric trainees into research-intensive faculty careers in academic medicine. Successful applicants will generally have both MD and PhD degrees, or be MD’s with a Master’s degree or other substantial research experience (including publications). Trainees in the PePSTP are encouraged to consider participating in the  Accelerated Research Pathway  (i.e., fast-tracking) as defined by the American Board of Pediatrics; to date,  about 60%  of our PePSTP trainees have elected to follow the ARP.

The PePSTP is dedicated to training young scientists and preparing them for successful careers in academic medicine. The program focuses on the period from the completion of the combined MD/PhD degree through the clinical and post-doctoral research training years, with the goal of achieving full-time academic appointment as an investigator. The PePSTP combines the intensive clinical training environment of St. Louis Children’s Hospital with rigorous scientific training in the world-renowned laboratories at Washington University. Presuming successful progress within the Categorical Pediatrics Residency Program, trainees enjoy  preferential access into any of the clinical fellowships  offered within the Department of Pediatrics. Fellowship research training (beginning in Year 4 if fast-tracking, Year 5 if on standard track) can be conducted within any laboratory across the broad biomedical research landscape of Washington University.

Eligible applicants include graduates with a combined MD/PhD degree, or an MD degree and a strong record of scientific experience, including publications. PePSTP trainees must fulfill all eligibility requirements for our Categorical Pediatrics training program. The most competitive candidates will have a strong commitment to a research career in academic medicine (including subspecialty fellowship training following residency) and an outstanding academic record.

Under-represented in medicine (URiM) Students:  Learn more about the  Kornfeld Post-Bac initiative  seeking to address limited representation of minorities and disadvantaged populations in medicine and the biomedical workforce.

All MD/PhD applicants should use ERAS to apply to the PePSTP track at SLCH.  For an MD/PhD applicant to be considered for PePSTP, a recommendation letter from the applicant’s PhD mentor or research supervisor must be included within the ERAS application materials. In addition, the ERAS Personal Statement should encompass the research experience of the applicant and should be specific and detailed regarding future plans for academic career development. 

In the current season, interviews for all MD/PhD residency applicants will be held by Zoom  in October through January and consist of two days:  the first (Thursday) a traditional residency interview, and the second (Friday) focused on PePSTP program details and research training opportunities.

Applicants who wish to be considered for both the PePSTP and categorical tracks should apply to both tracks in ERAS.

• PePSTP: 1869320C1
• Categorical: 1869320C0

PePSTP Trainees are guaranteed funding for both their clinical training years and their years of post-doctoral research. Senior fellows are encouraged to seek additional extramural funding (e.g., NIH K awards) to facilitate a subsequent transition to their first academic faculty position.

PePSTP Trainees receive additional funds to support their career development that include:

• Internship (Year 1) – $3,000 for the purchase of computers, software, books
• Years 2 and 3 – $2,000 per year for travel to national meetings or purchases of software or books
• Years 4, 5 and 6 –  $10,000 annual supplement to salary  (reflected in the stipends shown below)

Program structure

Clinical training.

Pediatrics Training:   Trainees will complete their internship and residency years within our Categorical Pediatrics Residency Program. Trainees who participate in the American Board of Pediatrics  Accelerated Research Pathway  (i.e., fast-tracking) will begin their subspecialty fellowship training during their third post-graduate year (PGY3) in lieu of their senior resident year in Pediatrics.

Clinical Fellowship Training:  Trainees will complete the required clinical subspecialty training as outlined by their ABP subspecialty boards. This typically entails 12 to 18 months total of clinical activities, depending on the specific fellowship chosen.

Research training

The selection of an appropriate post-doctoral training environment is critical to the success of the physician-scientist trainee. To assist this critical selection process, trainees are closely mentored by the program directors and the relevant division chiefs and fellowship directors.  Trainees will attend annual Department of Pediatrics Research Retreat and Career Development Retreat, in addition to retreat events offered by each Department and Research Program with the Graduate Division of Biology and Biomedical Sciences.

Trainees are not limited to working within Pediatrics, but are encouraged to explore the broad and deep research environment across Washington University and can choose any laboratory in which to complete their post-doctoral research training. For specific information, see the faculty research listings the Division of Biology and Biomedical Sciences and the School of Medicine . Also, the  Children’s Discovery Institute  is a useful resource for residents, fellows, and faculty.

Trainees can enroll in or audit courses offered through the  Division of Biology and Biomedical Sciences  and the  Institute for Clinical and Translational Sciences  covering every aspect of contemporary biomedical and clinical research.

Seminar series

PSTP Trainees from Pediatrics, Medicine, and Pathology participate in seminar series and retreat activities focused on research in medicine.

• Annual PSTP Symposium and Spring Talks series, featuring dinner with established physician-investigators
• Discussion in Medical Research. Joint seminar series with the Washington University MD-PhD (MSTP) program in which faculty members discuss their research programs and career paths

In addition, PePSTP Trainees attend:

• Pediatric Molecular Medicine Seminar: This series is centered on recent developments in molecular medicine. In addition, senior trainees discuss their research at this weekly forum
• Annual Department of Pediatrics Research Retreat
• Annual Pediatric Fellows’ Career Development Retreat

PePSTP trainees have full access to the activities and programs of the  Division of Physician-Scientists , and often attend weekly seminar series and special lectures offered by the relevant basic science programs within the Graduate  Division of Biology and Biomedical Sciences .

Contact information

Anthony french, md, phd.

PePSTP Co-director Email: [email protected]

David Hunstad, MD

PePSTP Co-director Email: [email protected]

Are you ready?

Learn more about our application process.

Current trainees

Matthew Biehl, MD, PhD

Medical School: University of Illinois College of Medicine at Chicago

Graduation Year: 2020

Subspecialty: Nephrology Fellow (ARP)

Lena Dang, MD, PhD

Medical School: Washington University in St. Louis

Graduation Year: 2021

Subspecialty: Cardiology

Kevin Graepel, MD, PhD

Class of 2023

Medical School: Vanderbilt University

Subspecialty: Critical Care

Matthew Grunewald, MD, PhD

Medical School: University of Iowa

Subspecialty: Rheumatology

Eric Hawley, MD, PhD

Medical School: Indiana University

Subspecialty: Hematology/Oncology

Jonathan Liang, MD, PhD

Class of 2026

Medical school: Yale School of Medicine

Graduation year: 2023

Subspecialty: Rheumatology & AIPM

Jerome Molleston, MD, PhD

Medical School: Perelman School of Medicine at the University of Pennsylvania

Graduation Year: 2018

Subspecialty: Gastroenterology Fellow (ARP)

Research Mentor:    Dr. Megan Baldridge

Lance Peterson, MD, PhD

Graduation Year: 2017

Subspecialty: Rheumatology Fellow (ARP)

Research Mentor:   Dr. Kodi Ravichandran

Daniel Pike, MD, PhD

Medical School: St. Louis University School of Medicine

Graduation Year: 2022

Maria Schletzbaum Bowler, MD, PhD

Medical school: University of Wisconsin

Courtney Vaughn, MD, PhD

Medical School: University of North Carolina at Chapel Hill School of Medicine

Daniel Verbaro, MD, PhD

Subspecialty: Gastroenterology

Tarin Bigley, MD, PhD

2022 Graduate

Current position: Assistant Professor of Pediatrics, Rheumatology

Current institution: Washington University in St. Louis School of Medicine

Research Mentor: Dr. Wayne Yokoyama

Funding: NIAID K08

Lab: bigleylab.wustl.edu

Nicole Brossier, MD, PhD

2018 Graduate

Current position: Assistant Professor of Pediatrics, Hematology/Oncology

Funding: Hyundai Hope on Wheels Young Investigator, NICHD K12

Lab: brossierlab.wustl.edu

Margaret A. Ferris, MD, PhD

Current position: Instructor in Pediatrics, Hematology/Oncology

Funding: NICHD K12

Research mentor: Dr. Dan Link

Leslie Fogel, MD, PhD

Current position: Instructor in Pediatrics, Rheumatology

Research mentor: Dr. Julie Bubeck Wardenburg

Sarah Greene, MD, PhD

Current position: Instructor in Pediatrics, Infectious Diseases

Research mentor: Dr. Gary Weil

Carmen Halabi, MD, PhD

2014 Graduate

Current position: Assistant Professor of Pediatrics, Nephrology

Funding: NIDDK K08

Lab: halabilab.wustl.edu

Jennifer Ikle, MD, PhD

Current position: Instructor in Pediatrics, Endocrinology

Current institution: Lucile Packard Children’s Hospital Stanford

Suong Nguyen, MD, PhD

Current position: Assistant Professor of Pediatrics

Current institution: Emory School of Medicine

Research mentor: Dr. Dan Goldberg

Anthony Orvedahl, MD, PhD

2016 Graduate

Current position: Assistant Professor of Pediatrics, Infectious Diseases

Funding: NIAID K08, NIH DP2

Research Mentor: Dr. Gary Silverman

Lab: orvedahllab.wustl.edu

David Rosen, MD, PhD

2015 Graduate

Funding: NIAID K08, R01, R42, R21

Lab: rosenlab.wustl.edu

Ellen Schill, MD, PhD

2023 Graduate

Current position: Instructor in Pediatrics, Newborn Medicine

Medical school: Washington University in St. Louis School of Medicine

Research Mentor:   Dr. Rodney Newberry

Erica Schmitt, MD, PhD

2021 Graduate

JOHN T. MILLIKEN DEPARTMENT OF INTERNAL MEDICINE

Division of Infectious Diseases

Rachel M. Presti, MD, PhD

Professor of Medicine

• Phone: 314-454-8215
• Fax: 314-454-5392
• Email: prestir@ nospam. wustl.edu

Rachel Presti, MD, PhD , is the Medical Director of the Infectious Disease Clinical Research Unit (IDCRU), which conducts clinical and translational research trials in HIV, PrEP, hepatitis, COVID-19, influenza, STIs, fungal infections, vaccines, microbiome and other infectious disease.  IDCRU has been an AIDS Clinical Trials Site since 1987.  She also co-directs the Center for Vaccine Research.

Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.  She has a background in immunology and also has an interest in facilitating translational research in vaccine development as well as viral pathogenesis.  She attends on the general ID consult services teaching fellows, residents, and students. She also sees patients in the virology clinic.

She is currently mentoring fellows and junior faculty in HIV and clinical trials.

Infectious Diseases Clinic 620 South Taylor Ave., Suite 100 St. Louis, MO 63110

• Principal Investigator, NIH – AIDS Clinical Trials Unit at Washington University School of Medicine
• Medical Director of the Infectious Diseases Clinical Research Unit (ID CRU)
• Section Head of HIV and other viruses and Sexual Health
• BA: Scripps College, Claremont, CA (1994)
• Medical Degree: Washington University School of Medicine, St. Louis, MO (2001)
• PhD: Washington University, St. Louis, MO (2001)
• Residency: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO (2003)
• Fellowship, Infectious Diseases: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO (2006)
• SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.   Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, Hansen L, Haile A, Klebert M, Pusic I, O’Halloran JA,  Presti RM , Ellebedy A.  Nature (accepted)
• CARD8 is an inflammasome sensor for HIV-1 protease activity.   Wang Q, Gao H, Clark KM, Mugisha CS, Davis K, Tang JP, Harlan GH, DeSelm CJ,  Presti RM , Kutluay SB, Shan L.Science. 2021 Mar 19;371(6535):eabe1707. doi: 10.1126/science.abe1707. Epub 2021 Feb 4.PMID: 33542150
• Human germinal centres engage memory and naive B cells after influenza vaccination. Turner JS, Zhou JQ, Han J, Schmitz AJ, Rizk AA, Alsoussi WB, Lei T, Amor M, McIntire KM, Meade P, Strohmeier S, Brent RI, Richey ST, Haile A, Yang YR, Klebert MK, Suessen T, Teefey S,  Presti RM , Krammer F, Kleinstein SH, Ward AB, Ellebedy AH.Nature. 2020 Oct;586(7827):127-132. doi: 10.1038/s41586-020-2711-0. Epub 2020 Aug 31.PMID: 32866963

View Rachel Presti’s publications on PubMed.gov »

• Pay My Bill

Beau M. Ances, MD, PhD

Top Doctors®

• Adult Neurology

Appointments

Sees patients for.

HIV, COVID, Creutzfeldt-Jakob disease, HIV associated neurocognitive disorders (HAND), HIV associated peripheral neuropathy, neuroAIDS, neurodegenerative diseases, aging, cognitive function, paraneoplastic disorders, post concussive syndrome, Down syndrome (DS), Alzheimer disease (AD), mild cognitive impairment (MCI), preclinical Alzheimer disease, post acute sequelae of COVID (PASC), COVID long haulers

Hospital Affiliations

• Barnes-Jewish Hospital
• Center for Advanced Medicine Neuroscience Center 4921 Parkview Place St. Louis , MO 63110 Suite: C Floor: 6 Fax: 314-747-8427 Appointments: 314-747-8423
• Taylor Ave. Building Extension 620 South Taylor Ave. St. Louis , MO 63110 Suite: Suite 2204 Fax: 314-747-8427 Appointments: 314-747-8423

Board Certifications

Academic title(s), publications & research.

1994 Health Planning and Finance, London School of Economics & London School of Hygiene and Tropical Medicine, London, UK

2001 University of Pennsylvania School of Medicine, Philadelphia, PA

1993 International Relations and Biology, University of Pennsylvania, Philadelphia, PA

2000 University of Pennsylvania School of Medicine, Philadelphia, PA

2005 Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA

2007 NeuroAIDS, University of California San Diego, San Diego, CA

Washington University Physicians are the medical staff of Barnes-Jewish Hospital and St. Louis Children's Hospital.

UW faculty accomplishments:

• The faculty generate more than $1.5 billion each year in funds for biomedical research
• 6 Nobel Laureates, including MSTP admissions committee member and mentor Linda Buck
• 10 recipients of Presidential Early Career Awards, including MSTP Director Marshall Horwitz and five other current MSTP mentors
• 15 Howard Hughes Medical Institute investigators, nine of whom are current MSTP mentors  or members of the MSTP admissions committee.
• 49 members of the US National Academy of Sciences, including MSTP Associate Director Mary-Claire King. All NAS members from the biological sciences serve as MSTP mentors.

Research Specialties

• Benaroya Research Institute More ▾
• Bettelli, Estelle PhD
• Buckner, Jane MD
• Ziegler, Steve PhD
• Fred Hutch Cancer Center More ▾
• Adair, Jennifer PhD
• Avgousti, Daphne PhD
• Bai, Jihong PhD
• Bedalov, Toni MD, PhD
• Bedford, Trevor
• Berger, Alice PhD
• Beronja, Slobodan PhD
• Bielas, Jason PhD
• Biggins, Sue PhD
• Bloom, Jesse PhD
• Bradley, Robert PhD
• Brent, Roger PhD
• Buck, Linda PhD
• Bullman, Susan PhD
• Cooper, Jonathan
• Emerman, Michael
• Fredricks, David MD
• Galloway, Denise PhD
• Ghajar, Cyrus PhD
• Gilliland, Gary MD, PhD.
• Goo, Leslie PhD MPH
• Groudine, Mark MD, PhD
• Gujral, Taran PhD
• Ha, Gavin PhD
• Halloran, Betz MD
• Henikoff, Steven PhD
• Hill, Geoffery MD
• Hockenbery, David MD
• Kiem, Hans-Peter MD, PhD
• Koch, Megan PhD
• Kugel, Sita PhD
• MacPherson, David PhD
• Malik, Harmit PhD
• McElrath, Julie MD, PhD
• Moens, Cecilia PhD
• Nabet, Behnam PhD
• Nelson, J. Lee PhD
• Nelson, Peter MD
• Olson, Jim MD, PhD
• Overbaugh, Julie PhD
• Prlic, Martin PhD
• Riddell, Stan MD
• Robins, Harlan PhD
• Rongvaux, Anthony PhD
• Roth, Mark PhD
• Salama, Nina PhD
• Singhvi, Aakanksha PhD
• Strong, Roland PhD
• Sullivan, Lucas PhD
• Tapscott, Stephen MD, PhD
• Tsukiyama, Toshi PhD
• Turtle, Cameron MD, PhD
• Wang, Pei PhD
• Warren, Edus MD, PhD
• Harborview Medical Center More ▾
• Barnabas, Ruanne DPhil
• Lukehart, Sheila MD
• Neumaier, John MD, PhD
• Poolos, Nicholas MD, PhD
• Puget Sound Blood Center More ▾
• Lopez, Jose MD
• Seattle Children’s Research Institute More ▾
• Beier, David MD, PhD
• Cherry, Timothy PhD
• Ferguson, Susan PhD
• Hevner, Robert MD, PhD
• Hoffman, Lucas MD, PhD
• Jensen, Michael MD
• Lawlor, Elizabeth MD PhD
• Rajagopal, Lakshmi PhD
• Rawlings, David MD
• Scharenberg, Andrew MD
• Sodora, Don PhD
• Tamura, Glen MD, PhD
• Terry, Michelle MD
• University of Washington More ▾
• Adams-Waldorf, Kristina MD
• Aderem, Alan PhD
• Asbury, Chip PhD
• Averkiou, Mike PhD
• Baker, David PhD
• Barria, Andres PhD
• Berg, Celeste PhD
• Bothwell, Mark PhD
• Browning, Sharon PhD
• Byers, Peter MD
• Cangelosi, Gerard PhD
• Catterall, William PhD
• Chamberlain, Jeffrey PhD
• Chapman, Rachel PhD
• Chavkin, Charles PhD
• Chiu, Daniel PhD
• Cookson, Brad MD, PhD
• DeForest, Cole PhD
• Doulatov, Sergei PhD
• Dunham, Maitreya PhD
• Eichler, Evan PhD
• Elkon, Keith MD
• Emerman, Michael PhD
• Fairhall, Adrienne PhD
• Fang, Ferric MD
• Farquhar, Carey MD
• Fetz, Eberhard PhD
• Fields, Stanley PhD
• Fowler, Doug PhD
• Freedman, Benjamin PhD
• Fuller, Deborah PhD
• Gale, Michael PhD
• Gelb, Michael PhD
• Gerner, Michael PhD
• Giachelli, Cecilia PhD
• Goverman, Joan PhD
• Greenberg, Pete PhD
• Greenberg, Philip MD
• Hawkins, David PhD
• Heinecke, Jay MD
• Hoppins, Suzanne PhD
• James, Richard PhD
• Kaeberlein, Matt PhD
• Keene, Dirk MD PhD
• Kimelman, David PhD
• King, Mary-Claire PhD
• King, Neil PhD
• Klevit, Rachel PhD
• Kraemer, Brian PhD
• Kueh, Hao Yuan PhD
• Lagunoff, Michael PhD
• Liles, W. Conrad MD, PhD
• Loeb, Lawrence A. MD, PhD
• MacCoss, Mike PhD
• MacLellan, Robb MD
• Maly, Dustin PhD
• Mathieu, Julie PhD
• Monnat, Raymond PhD
• Moritz, Chet PhD
• Ojemann, Jeffrey MD
• Palmiter, Richard PhD
• Perkel, David PhD
• Perlmutter, Steve PhD
• Pun, Suzie PhD
• Rabinovitch, Peter MD, PhD
• Raible, David PhD
• Rao, Rajesh PhD
• Ratner, Buddy PhD
• Ratner, Dan PhD
• Reding, Kerryn PhD
• Reh, Tom PhD
• Reniere, Michelle PhD
• Reyes, Jorge MD
• Rieke, Fred PhD
• Rubinstein, Jay MD, PhD
• Russell, David MD, PhD
• Salipante, Steve MD, PhD
• Samson, Werner MD, FACC, FACP
• Shendure, Jay MD, PhD
• Smith, Jason G.
• Smith, Kelly MD, PhD
• Stayton, Patrick PhD
• Steinmetz, Nick PhD
• Stella, Nephi PhD
• Stergachis, Andrew MD, PhD
• Stetson, Daniel PhD
• Theberge, Ashleigh PhD
• Theriot, Julie PhD
• Trapnell, Cole PhD
• VanVoorhis, Wesley MD, PhD
• Varani, Gabriele PhD
• Veesler, David
• von Moltke, Jakob PhD
• Waterston, Bob MD, PhD
• Weir, Bruce PhD
• Wong, Rachel PhD
• Woodrow, Kim PhD
• Woodward, Josh PhD
• Yager, Paul PhD
• Young, Jessica PhD
• Zheng, Ning PhD
• UW South Lake Union Campus More ▾
• Davis, Jennifer PhD
• Hawn, Thomas MD, PhD
• Horwitz, Marshall MD, PhD
• Miller, Daniel MD, PhD
• Mullins, Jim Phd
• Murry, Charles MD, PhD
• Neitz, Maureen
• Nghiem , Paul MD, PhD
• Pepper, Marion, PhD
• Regnier, Michael PhD
• Ruohola-Baker, Hanale PhD
• Savan, Ram PhD
• Stevens, Kelly PhD
• Aging More ▾
• Biochemistry More ▾
• Bioengineering More ▾
• Biostatiscs More ▾
• Cancer More ▾
• Cell & Developmental Biology More ▾
• Diabetes More ▾
• Epidemiology More ▾
• Gene Therapy More ▾
• Genetics More ▾
• Global Health More ▾
• Hematopoietic stem cell transplantation More ▾
• Immunology More ▾
• Microbiology More ▾
• Neuorobiology More ▾
• Neuroscience More ▾
• Pharmacology More ▾
• Signal Transduction More ▾
• Stem Cell More ▾
• Vascular Disease More ▾
• Virology More ▾
• Admissions Committee More ▾
• Cheng, Heather MD, PhD
• Directors More ▾
• Executive Committee More ▾
• Mentors More ▾
• Lee, Su-In PhD
• Rotation Mentors More ▾
• Director’s Welcome
• Our Directors
• UW MSTP History
• Program Overview
• Event Calendar
• Journal Club Archive
• Institutions
• Departments
• Admissions Overview
• How To Apply
• Interview Visit
• Prerequisites
• Current MSTP Students
• Student Perspectives
• MSTP Student Council
• Residency Matches
• Cassia Wagner, A Week in the Life
• Alec Gibson & Ted Gobillot, A Week in the Life
• What’s Happening
• UW Support Resources
• Alumni in the News
• MSTP Alumni

Be boundless

Connect with us:.

© 2024 Medical Scientist Training Program, University of Washington | Seattle, WA

Center for Diabetes Translation Research

Call for potential mentors! – WashU NIDDK STEP-UP program

On behalf of  Ana Maria Arbelaez, MD, MSCI ,  Dominic Reeds,MD  and  Rita Brookheart,PhD ,  —  

Mentors needed! We invite you to serve as a potential mentor for the  Short Term Research Experience to Unlock Potential (STEP-UP) Program ! Sponsored by the NIDDK and under the direction of WashU clinician-researchers,  the STEP-UP program introduces young investigators under-represented in medicine (URiM) to medical research related to nutrition, obesity, diabetes and related disorders (NODR). The ten-week intensive summer program includes, a mentored biomedical research experience, didactic coursework and weekly professional development seminars. 

Experienced researchers are needed to guide STEP-UP students as full-time members of their research team in order for them to:  

• Gain insight into the infrastructure of research operation 
• Witness the collaborative process of sharing techniques and implementing new endeavors 
• Develop critical thinking, problem solving, and analytical skills 
• further their research interests and more! 

We encourage, but do not require, students to pursue research within the NIDDK mission areas but they are welcome to explore other research area interests. If you’d like to be considered as a potential WU mentor for the STEP-UP Program, please complete the survey, linked below. 

https://redcap.wustl.edu/redcap/surveys/?s=4DDATJNJYM3PHL8A

We look forward to potentially working with you! If you have any questions, please contact  [email protected]  or Mary Katherine Townsend, STEP-Up Program Coordinator at  [email protected] .  

• Program Finder
• Admissions Services
• Course Directory
• Academic Calendar
• Hybrid Campus
• Lecture Series
• Convocation
• Strategy and Development
• Implementation and Impact
• Integrity and Oversight
• In the School
• In the Field
• In Baltimore
• Resources for Practitioners
• Articles & News Releases
• In The News
• Statements & Announcements
• At a Glance
• Student Life
• Strategic Priorities
• Inclusion, Diversity, Anti-Racism, and Equity (IDARE)
• What is Public Health?

21st Annual Edward and Nancy Dodge Lecture

Department & Center Events 

This year’s annual Dodge Lecture will feature  Lance Price, MS, PhD ‘06 , professor at the George Washington University’s Milken Institute School of Public Health and the founding director of the Antibiotic Resistance Action Center.

The Johns Hopkins Center for a Livable Future and the Department of Environmental Health and Engineering bring you the 21 st Annual Edward and Nancy Dodge Lecture: 

Quantifying Disease Risk from Food Animal Production: It’s Harder Than It Looks

Lance B. Price, MS, PhD '06 Professor, Milken Institute School of Public Health Founding Director, Antibiotic Resistance Action Center, George Washington University 

The lecture will be followed by a reception for in-person attendees.

Contact Info